Immunoclin (Immunoclin) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Immunoclin's net issuance of preferred for the three months ended in Oct. 2014 was $0.00 Mil. The number is 0, which means that Immunoclin has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Immunoclin's net issuance of preferred for the trailing twelve months (TTM) ended in Oct. 2014 was $0.00 Mil.

Immunoclin Net Issuance of Preferred Stock Historical Data

The historical data trend for Immunoclin's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Net Issuance of Preferred Stock Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Net Issuance of Preferred Stock

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Net Issuance of Preferred Stock	Get a 7-Day Free Trial									-	-	-	-	-

Immunoclin Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Oct. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Immunoclin Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Immunoclin's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines